Electromed, Inc. (ELMD)
Stock analysis · AMEX · Healthcare · Medical - Devices
Electromed, Inc. (ELMD) is a publicly traded company in the Healthcare sector. Latest price: $26.66. Market cap $220.93M. Trailing PE 19.46. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About Electromed, Inc.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. E…
Valuation
| P/E (TTM) | 19.46× |
|---|---|
| P/S (TTM) | 2.99× |
| P/B | 4.08× |
| PEG | 0.35× |
| P/FCF (TTM) | 23.88× |
| EV / EBITDA | 13.11× |
| EV / Sales | 2.72× |
| Earnings Yield | 5.13% |
| Free Cash Flow Yield | 4.19% |
Fundamentals
| Enterprise Value | $200.62M |
|---|---|
| Revenue (TTM) | $73.78M |
| Net Income (TTM) | $11.33M |
| Free Cash Flow (TTM) | $9.24M |
| Net Debt | -$20.32M |
| Working Capital | $45.15M |
| Gross Margin | 78.54% |
| Operating Margin | 18.82% |
| Net Margin | 15.32% |
| Return on Equity | 23.38% |
| Return on Invested Capital | 20.19% |
Peers
Recent News
- Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026
- Cytosorbents (NASDAQ:CTSO) versus Electromed (NYSE:ELMD) Head to Head Comparison
- Squarepoint Ops LLC Purchases Shares of 19,498 Electromed, Inc. $ELMD
- Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event
- Electromed: Contrarian 'Buy' With SmartVest
Related
Browse more tickers: sitemap